Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents Post date May 13, 2022 Tags Calabadion ← Migraine pathophysiology: lessons from mouse models and human genetics → Sensitivity to acute cerebral ischemic injury in migraineurs: A retrospective case-control study
Neurovascular Research UnitNeurovascular Research Unit